GSK Gsk Plc

TIDMGSK

RNS Number : 9406M

GlaxoSmithKline PLC

12 May 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc ('GSK') in respect of the under-mentioned Persons Discharging Managerial Responsibilities ('PDMR') on 11 May 2015:

 
 PDMR         GSK Deferred Annual Bonus Plan 
-----------  ------------------------------------- 
 E Walmsley   Exercise of a nil priced option 
               over 12,432 shares and 1,679 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 7,478. 
-----------  ------------------------------------- 
 P Vallance   Exercise of a nil priced option 
               over 24,907 shares and 3,363 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 14,983. 
-----------  ------------------------------------- 
 C Thomas     Exercise of a nil priced option 
               over 17,986 shares and 2,429 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 10,819. 
-----------  ------------------------------------- 
 D Redfern    Exercise of a nil priced option 
               over 14,644 shares and 1,977 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 8,809. 
-----------  ------------------------------------- 
 

The fair market value of an Ordinary Share at the point of exercise on 11 May 2015 was GBP14.73.

The Company and the above-mentioned PDMR's were advised of this transaction on 12 May 2015.

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

12 May 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLLFFEEFBBBK

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024

Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024